In the News
Recent Technology Advances Transforming Drug Discovery and Development
As demands for safe and efficacious pharmaceutical drugs grow, technological solutions will be of increasing interest that reduce barriers to clinical success rather than simply shifting bottlenecks and necessitating new compromises in the discovery and development process. Discussed here are:
(1) Target discovery and validation – impact of nanofluidic real-time qPCR technologies;
(2) Advances in early stage compound screening – impact of high throughput, microfluidic mass spectrometry, and (3) Incorporating ADME/Tox data earlier in drug discovery.
qPCR Methods Expand Rapidly: High-Throughput Platforms and Real-Time Profiling Advance Discipline
[Nov 1 2008 (Vol. 28, No. 19)]
by David W. Daniels, Ph.D.
November 03, 2008,
Full Text
Applied Biosystems Launches New High-Throughput Genotyping System
TaqMan® OpenArray™ Genotyping System simplifies workflows and reduces cost of a wide range of validation and screening applications
October 21, 2008,
Full Text
University of Toledo Scientist Studying New Test to Predict Outcomes for Lung Cancer Patients
University of Toledo News
October 02, 2008,
Full Text
BioTrove Plants the Seed of New Market in Biofuels
Mass High Tech, Volume 25, Number 24
June 08, 2007, Click to Download
Fluidics for qPCR, Diagnostics, & Biodefense
Genetic Engineering News, Vol. 26, No. 15
September 15, 2006,
Full Text
Biomarker Discovery and Identification
Genetic Engineering News, Vol. 26, No. 14
August 14, 2006,
Full Text
Ready-to-Play Assays, Kits, and Libraries
Genetic Engineering News, Vol. 26, No. 4
February 04, 2006,
Full Text
BioTrove's Bob Ellis Targets Business Space between Arrays and PCR
GenomeWeb BioArray News
February 04, 2004,
Full Text
Achieving Massively Parallel Screening
Genetic Engineering News, vol. 23, No. 13
July 13, 2003, Click to Download